A total of 48 patients with sporadic medullary thyroid carcinoma (MTC) with no tumours, signs, or symptoms which may be attributed to MEN syndromes; with no family history of MTC or MEN2 syndrome; and with negative RET pathogenic variant status in genetic diagnostics were included in the study. Here, RET is linked to neoplasm.